Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation.

[1]  C. White,et al.  Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. , 2013, American journal of respiratory cell and molecular biology.

[2]  R. Rancourt,et al.  Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[3]  T. van der Poll,et al.  Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti‐inflammatory and antimicrobial effects in murine pneumococcal pneumonia , 2011, Journal of thrombosis and haemostasis : JTH.

[4]  R. Rancourt,et al.  Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation. , 2010, American journal of respiratory and critical care medicine.

[5]  T. Kadar,et al.  Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. , 2009, Toxicology and applied pharmacology.

[6]  M. Matthay,et al.  Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[7]  D. Lawrence,et al.  Structure-function relationships of plasminogen activator inhibitor-1 and its potential as a therapeutic agent. , 2007, Current drug targets.

[8]  T. Neff,et al.  Attenuation of half sulfur mustard gas‐induced acute lung injury in rats , 2006, Journal of applied toxicology : JAT.

[9]  P. Bass,et al.  Tissue factor pathway inhibitor: structure, biology and involvement in disease , 2006, The Journal of pathology.

[10]  R. Vijayaraghavan,et al.  Comparative Toxicity Studies Of Sulfur Mustard (2,2'-Dichloro Diethyl Sulfide) And Monofunctional Sulfur Mustard (2-Chloroethyl Ethyl Sulfide), Administered Through Various Routes In Mice , 2006 .

[11]  C. Hack,et al.  TAFI and PAI-1 levels in human sepsis. , 2006, Thrombosis research.

[12]  L Szinicz,et al.  History of chemical and biological warfare agents. , 2005, Toxicology.

[13]  N. Ohkura,et al.  Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region. , 2004, Antioxidants & redox signaling.

[14]  T. van der Poll,et al.  Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia , 2004, Thorax.

[15]  S. Idell.  Coagulation, fibrinolysis, and fibrin deposition in acute lung injury , 2003, Critical care medicine.

[16]  W. Hadden,et al.  Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. , 2002, American journal of respiratory and critical care medicine.

[17]  M. Carraway,et al.  Tissue factor in experimental acute lung injury. , 2001, Seminars in hematology.

[18]  P. Suter,et al.  Haemostatic Properties of Human Pulmonary and Cerebral Microvascular Endothelial Cells , 1997, Thrombosis and Haemostasis.

[19]  J. Harenberg,et al.  Tissue factor pathway inhibitor: proposed heparin recognition region , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[20]  H. Hemker,et al.  The Influence of Fibrinogen and Fibrin on Thrombin Generation - Evidence for Feedback Activation of the Clotting System by Clot Bound Thrombin , 1994, Thrombosis and Haemostasis.

[21]  R. Leimgruber,et al.  Renaturation and purification of human tissue factor pathway inhibitor expressed in recombinant E. coli. , 1994, Protein expression and purification.

[22]  A. Chang,et al.  Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. , 1993, The Journal of clinical investigation.

[23]  M. Gerritsen,et al.  Isolation, cultivation, and partial characterization of microvascular endothelium derived from human lung. , 1992, American journal of respiratory cell and molecular biology.

[24]  P. Ostergaard,et al.  Simultaneous presence of tissue factor pathway inhibitor (TFPI) and low molecular weight heparin has a synergistic effect in different coagulation assays , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[25]  B. Papirmeister,et al.  Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications , 1991 .

[26]  N. Mozier,et al.  Biosynthesis and urinary excretion of methyl sulfonium derivatives of the sulfur mustard analog, 2‐chloroethyl ethyl sulfide, and other thioethers , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  F. Lemaire,et al.  Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. , 1990, The New England journal of medicine.

[28]  P. Burri,et al.  Morphometric estimation of regional differences in the rat lung. , 1990, Experimental lung research.

[29]  S. Somani,et al.  Toxicodynamics of sulfur mustard. , 1989, International journal of clinical pharmacology, therapy, and toxicology.

[30]  S. Idell,et al.  Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage. , 1989, The Journal of clinical investigation.

[31]  J. McLarty,et al.  Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury. , 1988, The American review of respiratory disease.

[32]  R. Greene.  Pulmonary vascular obstruction in the adult respiratory distress syndrome , 1986, Journal of thoracic imaging.

[33]  H. Chapman,et al.  A fibrinolytic inhibitor of human alveolar macrophages. Induction with endotoxin. , 1985, The American review of respiratory disease.

[34]  P. D. Lawley,et al.  Molecular Mechanism of the Cytotoxic Action of Difunctional Alkylating Agents and of Resistance to this Action , 1965, Nature.

[35]  M. L. Anson,et al.  REACTION OF ENZYMES AND PROTEINS WITH MUSTARD GAS (BIS(β-CHLOROETHYL)SULFIDE) , 1946, The Journal of general physiology.